Kidney Disease and Glomerular Disorders
Fondazione Schena Centro Europeo Della Ricerca Sulle Malattie Renali focuses on idiopathic IgA nephropathy, with research centered on renal inflammation, proteinuria, and biopsy-defined patterns of kidney injury.
- IgA nephropathy
- Proteinuria
- Kidney biopsy-based classification
The sponsor’s clinical activity is directed toward identifying treatment strategies aligned with the severity and character of renal lesions in patients with glomerular disease.
Immunosuppressive Therapy in Renal Care
Its research interests include the use of corticosteroid therapy in patients with active kidney lesions, with attention to treatment selection in immune-mediated nephropathy.
- Corticosteroids
- Renin-angiotensin system blockers
- Active renal lesions
These studies examine therapeutic choices for patients with more inflammatory renal involvement, where control of urinary protein loss is a key clinical concern.
Chronic Kidney Injury and Supportive Treatment
The sponsor also investigates care for patients with chronic or moderate renal lesions, where supportive treatment is considered alongside disease-specific management.
- Chronic renal lesions
- Moderate renal lesions
- Supportive nephrology care
Research in this area includes the role of SGLT2 inhibitors in combination with established renal therapies for patients requiring non-steroidal treatment options.
Multicentre Nephrology Research
The clinical programme is built around multicentre collaboration in nephrology, linking a large network of research sites in the study of biopsy-guided treatment decisions.
- Collaborative renal research
- Biopsy-guided therapy
- Proteinuria reduction
This research environment supports focused investigation of treatment approaches for IgAN across different patterns of kidney involvement.
